Watch the full video on Radcliffe Cardiology here: Dr Susheel Kodali (Columbia University Medical Center, New York, NY, US) discusses the six-month outcomes of the TRISCEND II Pivotal Trial. Originally presented at TCT 2021, this is a randomized multicenter controlled trial aiming to evaluate the safety and effectiveness of the EVOQUE tricuspid valve replacement system. At 6 months, the results suggest positive outcomes, with a reduction in tricuspid regurgitation recorded in the majority of patients.
Discussion Points:
- The Evoque device
- Patient recommendations
- Aims of TRISCEND II
- Key Findings
- Next Steps
Recorded remotely from New York, 2021.
Interviewer: Jordan Rance
Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. We aim to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.
Музыка
Фильмы
ТВ Шоу
Категории видео
